PD-1 and PD-L1 antibodies in cancer: current status and future directions
Marcombe S, Fustec B, Cattel J, Chonephetsarath S, Thammavong P, Phommavanh N, et al
Beyond 6 Months: Long-term studies demonstrate that these medications continue to provide sustained benefits with ongoing treatment
Increased BBB permeability suggests loss of BBB integrity evidenced by EC degeneration, TJs decrease, and pericyte deterioration and detachment from ECs
Smarter obesity management for health plans
If someone has diabetes or takes blood sugar-lowering medications, they should always check in with a health care provider before starting or stopping any supplement